Fiji Unveils First National Child Safeguarding Policy

Fiji Unveils First National Child Safeguarding Policy

Why in the News?

Fiji has launched its first National Child Safeguarding Policy to strengthen child safety and protection mechanisms across all sectors. The policy introduces a Child Protection Code of Conduct, strict vetting systems, and risk mitigation strategies to combat abuse and ensure children’s welfare, including protection against counterfeit and falsified products that may harm their health.

Strengthening Child Protection Framework in Fiji:

• Historic Launch: Fiji’s government unveiled its first-ever National Child Safeguarding Policy, marking a milestone in the nation’s child protection framework and addressing concerns about counterfeit medicines and fake drugs that pose risks to children’s health.
• Inclusive Coverage: The policy applies to all institutions and organizations involved in providing services for children, including schools, NGOs, and community centers, emphasizing the need for pharmaceutical security and vigilance against counterfeit products.
• Key Objective: It aims to ensure that all services for children are delivered in a safe, respectful, and child-friendly environment, free from the dangers of falsified medical products and spurious drugs.
• Preventive Approach: The initiative emphasizes prevention of harm by addressing gaps in existing systems and introducing clear accountability mechanisms, including measures to combat the counterfeit drug market and strengthen the pharmaceutical supply chain.
• Regional Significance: Fiji’s move comes amid rising regional concern over child safety in the Pacific, where underreporting and limited resources hinder effective protection against threats such as medicine counterfeiting and drug falsification.

Key Features and Implementation Measures

• Code of Conduct: Introduces a mandatory Child Protection Code of Conduct for all professionals and volunteers working with children, including awareness about counterfeit medicines and fake medications.
• Safe Recruitment: Implements child-safe hiring practices, including criminal background checks and screening of individuals before recruitment, to prevent those involved in pharmaceutical counterfeiting from accessing vulnerable children.
• Risk Mitigation: Outlines tailored risk assessment and mitigation strategies for organizations to identify potential threats early, including the risks posed by substandard drugs and counterfeit pharmaceutical drugs.
• Institutional Responsibility: Makes institutions legally responsible for ensuring safe service delivery and timely reporting of abuse cases, including incidents related to counterfeit antibiotics or other falsified medicines.
• Cultural Sensitivity: Recognizes cultural taboos that often silence victims and promotes community awareness programs to encourage reporting and break stigmas, including those surrounding counterfeit medications and fake product use.